Aardvark Therapeutics Inc. Investors Beware: Class Action Deadline Approaching Fast#USA#New_York#Levi_&_Korsinsky#Aardvark_Therapeutics#AARD_class_action
Aardvark Therapeutics Inc. Investors Beware: Class Action Deadline Approaching Fast
Attention investors of Aardvark Therapeutics Inc. (AARD): A vital deadline is nearing for filing a securities class action. Act now to protect your interests.
third-news.com
September 17, 2026 at 2:15 PM
Aardvark Therapeutics Inc. Investors Beware: Class Action Deadline Approaching Fast#USA#New_York#Levi_&_Korsinsky#Aardvark_Therapeutics#AARD_class_action
Hagens Berman Notifies Investors of Class Action Against Aardvark Therapeutics for Securities Misrepresentation#USA#San_Francisco#Hagens_Berman#Aardvark_Therapeutics#AARD_class_action
Hagens Berman Notifies Investors of Class Action Against Aardvark Therapeutics for Securities Misrepresentation
Hagens Berman has announced a securities class action lawsuit against Aardvark Therapeutics, highlighting significant safety concerns about its drug ARD-101.
third-news.com
August 24, 2026 at 4:23 PM
Hagens Berman Notifies Investors of Class Action Against Aardvark Therapeutics for Securities Misrepresentation#USA#San_Francisco#Hagens_Berman#Aardvark_Therapeutics#AARD_class_action